Improvement of Non-Alcoholic Fatty Liver Disease in Mice by Intermittent Use of a Fasting-Mimicking Diet

被引:12
|
作者
Zhao, Jingyu [1 ]
Bai, Meijuan [1 ]
Wei, Siying [1 ]
Li, Chenchen [2 ]
Lv, Qi [3 ]
Chen, Yan [1 ,2 ]
机构
[1] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai 200031, Peoples R China
[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
[3] Tongji Univ, Sch Med, Tongji Hosp, Dept Med Imaging, Shanghai 200065, Peoples R China
基金
中国国家自然科学基金;
关键词
dietary restriction; fatty acid oxidation; fatty liver disease; lipolysis; obesity; REGENERATION;
D O I
10.1002/mnfr.202100381
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Scope Liver plays a central role in maintaining lipid homeostasis which is dysregulated in non-alcoholic fatty liver disease (NAFLD) caused by overload of dietary fat, increase in lipid synthesis, and alteration of fatty acid oxidation in the liver. In this study, we aimed to investigate whether intermittent calorie restriction using a fasting-mimicking diet (FMD) is able to slow down the progression of NAFLD in mice. Methods and Results This study analyzed the intervention activity of a FMD low in carbohydrate/protein but high in dietary fibers with a NAFLD mouse model induced by high-fat high-sucrose diet (HFHSD). Intermittent application of the FMD reduces HFHSD-induced obesity and glucose intolerance. The FMD decreases the size of adipocytes and elevates expression of lipolysis genes and HSL protein in white adipose tissue. HFHSD-induced lipid accumulation in the liver is reduced by the FMD, accompanied by a reduction of macrophage marker in the liver. RNA sequencing reveals that the expression of a number of genes involved in fatty acid oxidation is elevated by the FMD. Conclusion The findings indicate that intermittent application of the FMD can improve NAFLD, at least in part, through increased lipolysis in white adipose tissue and elevated fatty acid oxidation in the liver.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
  • [32] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [33] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    BMC Medicine, 15
  • [34] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [35] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [36] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [37] Diet and non-alcoholic fatty liver disease, a short narrative review
    Kwanten, W. J.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2023, 86 (01) : 306 - 310
  • [38] Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
    Abenavoli, Ludovico
    Milic, Natasa
    Peta, Valentina
    Alfieri, Francesco
    De Lorenzo, Antonino
    Bellentani, Stefano
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (45) : 16831 - 16840
  • [39] Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
    Semmler, Georg
    Datz, Christian
    Trauner, Michael
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 : S244 - S260
  • [40] Alimentary regimen in non-alcoholic fatty liver disease:Mediterranean diet
    Ludovico Abenavoli
    Natasa Milic
    Valentina Peta
    Francesco Alfieri
    Antonino De Lorenzo
    Stefano Bellentani
    World Journal of Gastroenterology, 2014, (45) : 16831 - 16840